Created in 2003 (United States), EMTRIVA own 32 sister brands and 17477 competing brands. The EMTRIVA brand is owned by Gilead Sciences, a company listed in New York. EMTRIVA is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Gilead Sciences
(EMTRIVA)
over 5 years*
USD 65.55